What does MW THERAPIE do?

MW THERAPIE is a physiotherapy practice in Gesves. Private Limited, started on 3 March 2022, 1 establishment.

What is the address of MW THERAPIE?

The registered office of MW THERAPIE is located at Petite Gesves 29, 5340 Gesves.

Is MW THERAPIE still active?

Yes. According to the CBE (31 October 2026) MW THERAPIE is active, legal situation “Normale toestand”, started on 3 March 2022.

Is MW THERAPIE registered on Peppol?

No, MW THERAPIE is currently not registered on the Peppol network.

What is the enterprise number of MW THERAPIE?

The enterprise number of MW THERAPIE is BE0782847804.

When was MW THERAPIE founded?

MW THERAPIE was founded on 3 March 2022.

Who are the directors of MW THERAPIE?

According to the 2025 annual accounts, the directors of MW THERAPIE are: Michel WANGNEUR.

Is MW THERAPIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 3 March 2022; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MW THERAPIE make in 2025?

MW THERAPIE posted a profit after taxes of € 25,263 in financial year 2025.

What is the revenue of MW THERAPIE?

As a small company, MW THERAPIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 52,708.

MW THERAPIE (Private Limited) - Gesves - BE0782847804

Dossier MW THERAPIE, printed on 31 October 2026 from databakkes.be/en/0782847804/mw-therapie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

MW THERAPIE from Gesves, company number BE0782847804, closed financial year 2025 with a result of € 25,263 after tax. For that financial year MW THERAPIE recorded a gross margin of € 52,708 and equity of € 69,368. Compared with financial year 2024, the result moved from € 39,216 to € 25,263. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 25, 2026.

What it is worth Growing

€ 69,368

▲ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 25,263

▼ 36% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 10,477

▼ 20% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 20,000 paid out

79 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 235

▼ 75% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 14,338

▼ 44% vs 2024

€ 11,438 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 120

▼ 81% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 3,620

▼ 18% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 35,708 Gross margin 2022: € 35,708 First fiscal year in the series	€ 56,271 Gross margin 2023: € 56,271 ▲ 58% vs 2022 (€ 35,708) Favourable step	€ 70,504 Gross margin 2024: € 70,504 ▲ 25% vs 2023 (€ 56,271) Favourable step	€ 52,708 Gross margin 2025: € 52,708 ▼ 25% vs 2024 (€ 70,504) Unfavourable step	▼ 25%
Profit after taxes	€ 13,675 Profit after taxes 2022: € 13,675 First fiscal year in the series	€ 26,514 Profit after taxes 2023: € 26,514 ▲ 94% vs 2022 (€ 13,675) Favourable step	€ 39,216 Profit after taxes 2024: € 39,216 ▲ 48% vs 2023 (€ 26,514) Favourable step	€ 25,263 Profit after taxes 2025: € 25,263 ▼ 36% vs 2024 (€ 39,216) Unfavourable step	▼ 36%
Equity	€ 17,675 Equity 2022: € 17,675 First fiscal year in the series	€ 44,188 Equity 2023: € 44,188 ▲ 150% vs 2022 (€ 17,675) Favourable step	€ 64,104 Equity 2024: € 64,104 ▲ 45% vs 2023 (€ 44,188) Favourable step	€ 69,368 Equity 2025: € 69,368 ▲ 8% vs 2024 (€ 64,104) Favourable step	▲ 8%
Total debts	€ 127,702 Total debts 2022: € 127,702 First fiscal year in the series	€ 86,801 Total debts 2023: € 86,801 ▼ 32% vs 2022 (€ 127,702) Favourable step	€ 49,892 Total debts 2024: € 49,892 ▼ 43% vs 2023 (€ 86,801) Favourable step	€ 20,905 Total debts 2025: € 20,905 ▼ 58% vs 2024 (€ 49,892) Favourable step	▼ 58%
Cash	€ 32,283 Cash 2022: € 32,283 First fiscal year in the series	€ 27,239 Cash 2023: € 27,239 ▼ 16% vs 2022 (€ 32,283) Unfavourable step	€ 13,155 Cash 2024: € 13,155 ▼ 52% vs 2023 (€ 27,239) Unfavourable step	€ 10,477 Cash 2025: € 10,477 ▼ 20% vs 2024 (€ 13,155) Unfavourable step	▼ 20%
Retained profit	€ 13,675 Retained profit 2022: € 13,675 First fiscal year in the series	€ 40,188 Retained profit 2023: € 40,188 ▲ 194% vs 2022 (€ 13,675) Favourable step	€ 60,104 Retained profit 2024: € 60,104 ▲ 50% vs 2023 (€ 40,188) Favourable step	€ 65,368 Retained profit 2025: € 65,368 ▲ 9% vs 2024 (€ 60,104) Favourable step	▲ 9%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 19,300 Dividend 2024: € 19,300 Unchanged (€ 0) Unchanged	€ 20,000 Dividend 2025: € 20,000 ▲ 4% vs 2024 (€ 19,300) Unchanged	▲ 4%
Bank debt	€ 48,911 Bank debt 2022: € 48,911 First fiscal year in the series	€ 36,952 Bank debt 2023: € 36,952 ▼ 24% vs 2022 (€ 48,911) Favourable step	€ 25,520 Bank debt 2024: € 25,520 ▼ 31% vs 2023 (€ 36,952) Favourable step	€ 14,338 Bank debt 2025: € 14,338 ▼ 44% vs 2024 (€ 25,520) Favourable step	▼ 44%
Balance sheet total	€ 145,377 Balance sheet total 2022: € 145,377 First fiscal year in the series	€ 130,989 Balance sheet total 2023: € 130,989 ▼ 10% vs 2022 (€ 145,377) Unchanged	€ 113,996 Balance sheet total 2024: € 113,996 ▼ 13% vs 2023 (€ 130,989) Unchanged	€ 90,272 Balance sheet total 2025: € 90,272 ▼ 21% vs 2024 (€ 113,996) Unchanged	▼ 21%

Key figures of MW THERAPIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MW THERAPIE?

What happened at MW THERAPIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 25, 2026 New annual accounts for financial year 2025: profit of € 25,263 (▼ 36% vs 2024). filed late Source: NBB ↗
Mar 3, 2022 New establishment in Gesves. KBO
Mar 3, 2022 Start of the company according to the CBE. KBO

In short

From € 13,675 profit in 2022 to € 25,263 profit in 2025.

Paid € 39,809 in corporate taxes since 2022.

Best year ever: 2024, with € 39,216 profit.

Paid out € 39,300 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Michel WANGNEUR

MW THERAPIE

Behind MW THERAPIE is Michel WANGNEUR.

Directors

According to the 2025 annual accounts

Michel WANGNEUR

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Petite Gesves 29

5340 Gesves

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0782.847.804

VAT number

BE 0782.847.804

Registered office

Petite Gesves 29, 5340 Gesves

Names & denominations

MW THERAPIE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

3 March 2022

Peppol

Not registered

Contact

[email protected] +32479420256

Activities · NACE

Activiteiten op het gebied van kinesitherapie

Ambulante revalidatieactiviteiten

View on CBE Public ↗ Annual accounts (NBB) ↗

MW THERAPIE

Warning lights

Financials

What happened to MW THERAPIE?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions